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Abstract
OBJECTIVES: The surgical approach to chronic pleural empyema is still controversial. Video-assisted thoracic surgery (VATS) debridement
and decortication has shown favourable outcomes, while the uniportal VATS (U-VATS) approach is still anecdotal. We report our experi-
ence with ultrasonographic (US) preoperative staging followed by U-VATS decortication for pleural empyema.
METHODS: We performed a retrospective analysis of patients who underwent surgical treatment of stage II and stage III pleural empyema
from 2012 to 2015. Pre-, intra- and postoperative data were investigated to evaluate outcomes including postoperative complications and
disease recurrence. Results were analysed according to preoperative US appearance of pleural space (stages A–E) and surgical approach
(thoracotomy vs U-VATS).
RESULTS: We performed 30 (47%) uniportal thoracoscopic pleural decortication and 34 (53%) open decortication for empyema in stage II
(40%) or III (60%) obtaining a complete debridement and decortication in all patients. In-hospital mortality was zero and overall morbidity
was 29%. U-VATS was associated with lower blood loss (118 ± 80 ml vs 247 ± 140 ml P < 0.001), lower chest tubes duration (5.6 ± 1.4 vs
10.6 ± 4.4 days P < 0.001), shorter hospital stay (6.7 ± 1.9 vs 12.2 ± 4.7 days, P < 0.001) and lower complications (10% vs 16%, P < 0.001).
Elevated US patterns (D–E) are associated with thoracotomy, higher blood loss, operative time and a significant incidence of
complications.
CONCLUSIONS: Uniportal thoracoscopic decortication for pleural empyema is a safe and effective approach for selected patients based
on a combination of clinical and imaging staging. US patterns well corresponded with intraoperative pleural findings and showed a prog-
nostic value.
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INTRODUCTION
The recent literature demonstrated that an early and aggressive
minimally invasive approach for empyema in phase II provides
rapid relief from infection and guarantees lower morbidity rate,
short hospital stay, lower costs and clinical resolution [1–4]; how-
ever, the role of video-assisted thoracic surgery (VATS) in later
organizing phase empyema is still controversial. The objective
of surgical treatment of chronic pleural empyema is to drain
infected collections from pleural cavity and to achieve a com-
plete lung re-expansion by removal of visceral cortex. Some stud-
ies [5–8] showed that VATS decortication is feasible and safe with
similar outcomes in terms of resolution of infection and
functional results, and some advantages related to less morbidity
and better visualization of entire pleural cavity in comparison to
thoracotomy. A recent consensus statement by European
Association for Cardio-Thoracic Surgery (EACTS) [9] concluded that
VATS has an important role in the management of pleural empy-
ema determined by its safety and effectiveness both in stages II
and III, but thoracotomy still plays a fundamental role especially
for decortication. The application of the uniportal VATS (U-VATS)
approach for the treatment of pleural infection is not yet well iden-
tified, but it could be useful to minimize surgical trauma.
Diagnostic imaging (chest X-ray, computed tomography [CT]
scan and chest ultrasonography) are useful to determine the
boundary pleural effusion, the pleural thickening, the presence of
adhesions, loculations, septa and underlying pulmonary disease.
For these purposes, chest ultrasonography (US) has advantages
over CT including safety, absence of radiation exposure, non-
invasiveness, low-cost and identification of the distribution of
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pleural fluid, the presence of loculations and septa and permit to
guide real-time manoeuvres [10]. However, US does not have a
clear role in defining the time of surgery and suggesting the sur-
gical approach which is chosen according to the onset of symp-
toms, the infectious status and the empyema stage. These
information, related to other clinical data, can help the clinicians
to optimize the timing for surgical procedure and planning a tail-
ored approach.
This study was undertaken to compare indications, clinical fea-
tures, ultrasonographic patterns and postoperative outcomes in
patients receiving U-VATS decortication for stage II or III pleural
empyema.
MATERIALS AND METHODS
This is a retrospective study using a prospective database of con-
secutive patients who underwent surgical debridement and de-
cortication for pleural chronic empyema from January 2012 to
December 2015 with minimally invasive U-VATS approach.
The preoperative management of pleural empyema in our
Unit was in accordance with the British Thoracic Society guide-
lines [11].
Preoperative diagnostic work-up included complete medical
history, blood sample analysis (red cells count, white cells count,
serum C-reactive protein and serum procalcitonin), electrocar-
diogram, emogas-analysis, chest X-ray, chest CT, chest ultrason-
ography, diagnostic thoracentesis or tube thoracostomy. The
surgical decision was made after a multidisciplinary consult in
the presence of the following criteria and after failed medical
therapy:
1. Persistence of septic status (with or without positive cultures)
2. Chronic or infected pleural fluid (free or septated, with or
without gas)
3. Pleural thickening that causes entrapped lung
4. Patient fit for open or VATS surgery.
Patient with complicated parapneumonic effusion had a pleu-
ral fluid pH inferior to 7.1, glucose level inferior to 40 mg/dl, LDH
greater than three times the normal serum value, multi-loculated
effusion (class 4 or 5 of Light’s classification); patients with pleural
empyema had a positive bacterial culture, frank pus on thora-
centesis and/or multi-loculated effusion on CT scan (class 6 or 7).
Ultrasonographic staging
We performed chest ultrasonography (US) with 3.5–7.5 MHz lin-
ear or sector probe twice: in the preoperative period during the
decision-making process and in the operating room before surgi-
cal incision.
We classified the ultrasonographic appearance in this way,
modifying the classification of US patterns of pleural effusion
described originally by Yang et al. [12] in 1992 and Heffner et al.
[10] in 2010:
A. Simple (anechoic)
B. Complex (containing heterogeneous echogenic material)
C. Septated with countable loculations
D. Septated without countable loculations
E. Homogeneously echogenic with pleural hyper-reflectivity.
These patterns are associated with different stage: classically,
stage III empyema shows a sonographic appearance D or E, stage
II is associated more frequently with patterns C and D and stage I
occurs almost exclusively with A appearance. The ‘new pattern D’
represents the intermediate stage between hyper-echogenic
pleural fluid associated with visceral pleural thickness with fi-
brous peel (pattern E, empyema stage III) and the presence of fi-
brinous septa forming multiple loculations with fluid that is
characteristic of empyema stage II (Table 1 and Fig. 1).
The comparison between US and CT scan was considered not
feasible for the presence of several confounding factors as time
(the CT scan was often performed days or weeks before surgery
and we decided to not repeat) and professional skills (US was al-
ways done by a trained surgeon, not by a radiologist).
The surgical approach was decided based on preferences, atti-
tudes and background of the surgeon and integrated with clinical
history and radiological findings. For patients with recent symp-
toms onset, short antibiotic therapy, ultrasonographic pattern C
or D (but not exclusively), surgeons skilled in VATS procedures
proposed U-VATS approach, whereas in other cases, we used
thoracotomy. To test the feasibility, safety and the outcomes of
U-VATS decortication, we compared the data of patients
undergoing minimally invasive surgery with those of the patients
with thoracotomic access.
Uniportal thoracoscopic technique
The U-VATS procedure was performed with general anaesthesia
and one-lung ventilation using a double-lumen endotracheal
tube or bronchial blocker. We used a single incision of 3–4 cm
planned according to the ultrasonographic appearance of the
pleural space (usually at the seventh or eighth intercostal space
in the posterior axillary line) for 5 mm or 10 mm 30 camera and
endoscopic and standard instruments. This incision was located
in the lowest area of the hemithorax, over the diaphragm (previ-
ously identificated with US) and this access allowed to reach all
regions involved by inflammatory process and also allowed to
easily free the diaphragmatic surface of the lower lobe (Fig. 2).
The first phase involved the removal of all adhesions and
inflammatory effusion. After complete debridement, the inflam-
matory peel was separated from the visceral pleura and
subpleural lung with a blunt and sharp dissection avoiding im-
portant parenchymal injury. The diaphragm was also cleaned up
by the typical inflammatory reaction and diaphragmatic surface
of the lung was completely freed to restore the diaphragmatic
movements. For blunt dissection, we used a handmade long-
Table 1: Comparison of classification of pleural effusion ac-
cording to Yang and Heffner and our classification
Yang 1992 US pleural
effusion classification
Our classification
A. Anechoic A. Anechoic
B. Complex non septated B. Complex (containing heterogeneous
echogenic material)
C. Complex septated C. Septated with countable loculation
D. Septated without countable loculation
D. Homogeneously
echogenic
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angled oval bone curette that allowed excellent removal of vis-
ceral peel without causing major parenchymal wound. Bleeding
was managed with electrocautery and hot packing. In some
cases, we performed lung or pleural biopsies. The procedure
ended when we accomplished a full lung re-expansion and
placed two 28F chest tubes under endoscopic vision on dia-
phragm and at the apex.
Patients were extubated in the operating room and were trans-
ferred to our thoracic surgery recovery area for postoperative
monitoring. Chest tubes were maintained on -20 cm H2O of suc-
tion for 36–48 h postoperatively and criteria for removal was ab-
sence of air leak, good lung re-expansion, bacterial culture
negative and less than 200 ml of drainage in 24 h. Patients were
followed with chest X-ray 2 weeks after discharge and monitored
regularly clinically and radiologically for 12–24 months.
Statistical analysis
Statistical analysis was completed with SPSS 16.0 software (SPSS
Inc., Chicago, IL), continuous data were expressed as mean and
standard deviation and compared with Student’s t-test, while the
Fisher exact test or v2 test were used for difference between pro-
portions. A P-value less than 0.05 was considered statistically
significant.
RESULTS
From January 2012 to October 2015, we operated 64 patients af-
fected by pleural empyema in stage II (n = 26, 40%) and stage III
(n = 38, 60%).
The mean age of the population was 57.8 ± 16.4 years with a
high prevalence of men (40/64, 62%). The 34% of patients were af-
fected by predisposing conditions such as chronic obstructive pul-
monary disease, alcoholism, diabetes mellitus and chronic heart
disease. The most common presenting symptoms were fever (59%),
thoracic pain (10%) and dyspnoea (31%). The prevalent cause of
pleural empyema was complicated bacterial pneumonia (85%);
Figure 1: Ultrasonographic patterns of our classification.
Figure 2: Identification of the operative working space and access with ultra-
sonography. The white line represents the US position of the diaphragm; the
red line is the US distribution of the effusion and the yellow line is the skin inci-
sion based on US appearance of pleural space.
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other causes were chest trauma and subsequent retained haemo-
thorax (11%) and previous thoracentesis (4%). All patients were
treated with broad spectrum antibiotics for 8.7 ± 3.7 days without
clinical improvement and chest tube was inserted in 23 patients
(35%); no fibrinolytic therapy had been attempted in our series.
Decortication was considered complete by the operating sur-
geon in all patients.
In our series, there was no in-hospital mortality and overall
complication rate was 29%; the most common was bleeding
requiring blood transfusions in 9 patients (14%) and re-
intervention in 4 (6%). Late recurrence was reported in 2 patients
(3%), 1 of whom underwent U-VATS decortication, documented
and confirmed with chest-CT scan. These individuals received a
second surgery. We also registered 3 prolonged air leaks and 1
respiratory failure that required tracheostomy. Sixty-two patients
(96%) were stable at discharge and all of them had an improved
lung re-expansion of the affected lung. This condition has re-
mained stable at the first follow-up after decortication and at an-
nual clinical and radiological follow-up.
Dividing patients according to surgical approach, we found 30
patients (46%) who underwent U-VATS debridement and decor-
tication (Group A), while 34 (54%) were operated by thoracot-
omy (Group B). Demographic and preoperative characteristics
are reported on Table 2.
There were no differences in the demographic and clinic-
radiological findings (sex, age, comorbidities, symptoms, empy-
ema staging) between the groups.
Comparing intraoperative and postoperative data, we found
statistical differences for intraoperative blood loss, postoperative
hospital stay, chest drain duration and postoperative complica-
tions (10% vs 47%, P < 0.001) as depicted in Table 3. We had three
conversions from U-VATS to biportal or triportal VATS decortica-
tion (3/30 10%), none from U-VATS to thoracotomy.
Dividing patients according to US preoperative appearance
(Table 4), we noted that elevated US pattern (grade E) is strongly
associated with thoracotomy (n = 16, 89% vs n = 2, 11%; P < 0.001)
higher estimated blood loss, higher operative time and higher in-
cidence of complications (n = 12, 19% vs n = 7, 10%; P < 0.001).
We found also that conversion rate was strongly associated to
elevated ultrasonographic appearance: in fact, only patients with
US pleural pattern E underwent conversion.
DISCUSSION
The objective of surgical treatment of chronic pleural empyema
is to drain infected collections from pleural cavity and to achieve
a complete lung re-expansion by removal of visceral cortex.
Decortication by open thoracotomy or VATS is proven superior
to medical treatment for advanced empyema [13]. VATS has
been demonstrated to allow effective drainage and removal of
loculations of empyema in stage II [14], but its role in phase III
(organizing phase) is still debated [3, 14–15]. Decortication is
traditionally accomplished via thoracotomy, but VATS has some
advantages such as less morbidity related to surgical trauma, bet-
ter visualization of the entire pleural cavity, and equivalent out-
comes in terms of resolution of infection and functional results
[3, 6, 16]. In a large retrospective study of 420 patients conducted
Table 2: Demographical and clinical data of two groups







Mean age ± DS 57.8 ± 16.4 55 ± 16 64 ± 15 0.2
Male, n (%) 40/64 (62) 21 (70) 19 (56) 0.3
Symptoms
Fever, n (%) 38 (59) 20 (66) 18 (53) 0.5
Dyspnoea, n (%) 20 (31) 8 (26) 12 (35)
Chest pain, n (%) 6 (10) 2 (7) 4 (12)
Aetiology
Pneumonia, n (%) 50 (78) 23 (76) 27 (79) <0.001
Retained haemothorax, n (%) 7 (11) 0 7 (20)
Previous thoracentesis / iatrogenic, n (%) 3 (5) 3 (10) 0
Other, n (%) 4 (6) 4 (13) 0
Comorbid disease, n (%) 22 (34) 23 44 0.1
Chronic obstructive pulmonary disease (COPD) 1 3
Heart disease 1 4
Diabetes mellitus 3 0
Liver disease 2 2
Sepsis 0 3
Other 0 3
Duration of symptoms 19 ± 9 13 ± 4 25 ± 14 <0.001
Duration of antimicrobical treatment 8.7 ± 3.7 6.4 ± 1.8 11 ± 5.7 <0.001
Stage
II, n (%) 26 (40) 12 (40) 14 (41) 0.9
III, n (%) 38 (60) 18 (60) 20 (59)
US pattern
Septated with countable locolations, n (%) 25 (39) 13 (43) 12 (35) <0.001
Septated with uncountable locolations, n (%) 19 (30) 13 (43) 6 (18)
Homogeneously echogenic with pleural hyper-reflectivity, n (%) 20 (31) 4 (14) 16 (47)
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by Tong et al. [5] in 2010, VATS decortication is demonstrated as
safe, effective, with functional results comparable to thoraco-
tomic decortication. However, VATS decortication is associated
with shorter hospital stay, fewer prolonged air leaks, fewer blood
transfusions, fewer postoperative respiratory complications and
30-day mortality, suggesting that it is a reasonable approach for
all decortications. In a previous study of 2009, Cardillo et al. [7]
compared the clinical outcomes of thoracotomic decortication
and thoracoscopic decortication demonstrating the latter to be
better in terms of postoperative pain, air leaks and hospital stay.
Casali et al. [8] reported similar results but in addition showed
that VATS decortication had higher improvement in subjective
dyspnoea. A recent consensus statement by the European
Association of Cardio-Thoracic Surgery (EACTS) concluded that
VATS has an important role in the management of pleural empy-
ema because of its safety and effectiveness, both in stage II and
stage III, but thoracotomy plays a key role for obtaining complete
lung re-expansion in presence of pleural thickness and entrapped
lung [9].
The last frontier of minimally invasive thoracic surgery is
U-VATS approach that causes less and singular intercostal trauma
and potentially less postoperative pain and less morbidity.
U-VATS is used routinely for the management of recurrent pleu-
ral effusions, preoperative staging in lung cancer, treatment of
primitive spontaneous pneumothorax, palmar hyperhidrosis and
only in experienced hands for anatomic lung resections [17, 18].
Few papers report the use of U-VATS approach for empyema
treatment or decortication. In a small series (11 patients), Song
et al. reported a high conversion rate (55%) due to the difficulties
encountered in removing the thickened visceral pleura. For this
reason, they used more frequently a three portal conventional
VATS approach for removal of fibrous peel [19]. Marra et al. [20]
developed an original ‘hybrid’ technique of single access thoraco-
scopy using a classical video-mediastinoscope to debride the
cavity and disrupt all pleural septation. This approach was used
mainly for parapneumonic effusion (stage I) and empyema in
fibrino-purulent phase without conversion to thoracotomy and
with a low recurrence (6.5%) managed by redo single-VATS and
postoperative irrigation through chest tubes or open thoracos-
tomy. In larger experience of U-VATS procedure [17, 21] only a
small portion of patients, affected by early stage empyema, were
treated with single-port access without complications or mortal-
ity. In our report, we explained technical aspects of U-VATS de-
cortication and demonstrated its safety (absence of postoperative
mortality, lower morbidity) and its efficacy in terms of disease
control (lower rate of recurrence, n = 1, 3%) compared to the
standard thoracotomic approach.
U-VATS decortication is a complex and demanding procedure
that requires adequate skills and instrumentation because the ex-
ploration of the pleural cavity, the removal of adhesions and
pleural peel on delicate and infected tissue (with a high bleeding
risk) using a single access is very hard, laborious and sometimes
tedious. Blunt dissection could be facilitated by angled oval bone
curette and peanuts that allow gentle dissection over vulnerable
tissue. At the beginning, we had some bleeding caused by less ex-
perience, but we found very useful to pack the cavity with a hot
large sponge and using electrocautery devices such as bipolar
forceps. We had few prolonged air leaks, which may be due to
the correct dissection and removal of pleural peel and perhaps
to the use of sealants.
In our series, 38 patients (60%) were affected by chronic
empyema. Twenty underwent decortication by thoracotomy and
18 by U-VATS. Complete decortication and full lung re-
expansion was obtained in all patients. Even in this subgroup, we
observed a very low conversion rate and less recurrence, achiev-
ing similar functional results and better postoperative outcomes
than thoracotomy. Probably, this fact could be related to correct
preoperative staging also determined by accurate clinical and
radiological assessment. During the diagnostic phase, all patients
undergo chest X-ray, CT and ultrasonography (performed by






Operative time (m) 116 ± 28 135 ± 43 0.04 0.27–37.64
Estimated blood loss, ml 118 ± 80 247 ± 140 <0.001 70.52–187.18
Chest tube duration, days 5.6 ± 1.4 10.6 ± 4.2 <0.001 3.32–6.70
Postoperative complication, n (%) 3 (10) 16 (47) <0.001 0.31–0.71 (0.47)
Hospital stay, days 6.7 ± 1.9 12.2 ± 4.7 <0.001 3.67–7.39
CI: confidence interval; OR: odds ratio.
Table 4: Operative and postoperative data associated with US findings
US pattern E US pattern C-D P-value CI/(OR)
Estimated blood loss (ml) 330 ± 131 130 ± 80 <0.001 -235, 98 to -145, 60
Operative time (min) 142 ± 23 120 ± 40 0.46 -41.81 to 0.34
Thoracotomy, n (%) 16 (89) 2 (11) <0.001 1.76 to 28.21 (7.05)
Postoperative complication, n (%) 12 (19) 7 (11) <0.001 1.29 to 4.28 (2.35)
US: ultrasonography; CI: confidence interval; OR: odds ratio.
564 S. Bongiolatti et al. / Interactive CardioVascular and Thoracic Surgery
Downloaded from https://academic.oup.com/icvts/article-abstract/24/4/560/2929424
by Azienda Ospedaliera Careggi user
on 31 January 2018
surgeons); so imaging and medical history can define accurately
the empyema stage for a tailored treatment. In our experience,
ultrasonography is very sensitive in defining the presence of free
fluid (A) or corpuscolated fluid collection (B), loculations, cavities
and septa (stages C and D) and also pleural thickness is well
related with pleural fluid hyper-echogenicity (E). Our classifica-
tion differs from Yang and Heffner’s system for the presence of a
new intermediate pattern, identified by letter D, between hyper-
echogenicity of pleural effusion and visceral pleura, specific of
stage III and loculations that are associated frequently with stage
II. The impossibility to count these loculations may be inter-
preted by the presence of strong adhesions and significant vis-
ceral thickness that entrapped the lung, features proper to third
stage. In our series, all patients with US pattern D had empyema
in third phase and underwent decortication. We think that this
US appearance could be the feature of a transition phase be-
tween stages II and III.
Sonographic appearance plays an important role in the diag-
nostic process, defining accurately the empyema stage, the evo-
lution of pleural space and the timing of surgery or other
therapeutic manoeuvers. CT scan remains the gold standard
examination for the diagnosis and staging of pleural empyema,
but US has several advantages in terms of non-invasiveness (ab-
sence of radiation exposure) and immediacy as a real-time visu-
alization of the pleural space.
Also US is useful to plan the approach and the access and may
also have prognostic significance. A strong hyper-reflectivity of
visceral pleura associated with uncountable loculations forces us
to perform decortication. U-VATS approach is used more fre-
quently for US patterns C and D (n = 26/30, 86%) with few con-
versions to traditional VATS and no conversions to thoracotomy
that is used for chronic empyema in the presence of pattern E (n
= 16/20, 80%). This clearly demonstrated how the integration be-
tween the clinical data and ultrasonographical findings allowed a
precise identification of the stage and subsequently a tailored
surgical approach.
Our study did not show what were the appropriate techniques
or findings to identify the various stage of empyema; however,
CT loculations, pleural thickness and US hyper-reflectivity were
associated with higher stage of empyema.
US was also useful to plan the surgical access to pleural cavity
because it well defined the ‘working space’: with the patient in
lateral decubitus, we identified the position of diaphragm, the
distribution of effusion, septa and loculations and so we planned
the skin incision to obtain a wide range to reach the apex and
the diaphragm with a direction from anterior to dorsal region.
US had a fundamental preoperative role for planning the surgi-
cal approach but also had a predictive value for delineating pa-
tients with a higher risk of postoperative complications: US
pattern E and thoracotomic decortication were risk factors for
postoperative complications including bleeding, air leaks and re-
spiratory failure. Obviously, we reserved thoracotomy for more
advanced disease, and consequently complications were more
expected and more frequent.
This study is limited by its retrospective nature in a small series
analysed in a short period. Also we did not analyse functional
long-term results. Although a randomized prospective trial could
clarify debated issues and benefits of VATS, it is not practically
feasible.
The primary finding in this study was that the U-VATS ap-
proach gave equally effective treatment for empyema even in pa-
tients with advanced disease compared with thoracotomy. Both
provided the removal of all loculations and inflammatory visceral
peel and allowed complete lung expansion and obliteration of
pleural space that are fundamental goals of the surgical manage-
ment of pleural empyema. U-VATS approach could be an effect-
ive and safe alternative in well-selected patients with third-stage
empyema with an equivalent incidence of complications and late
recurrence.
Secondary ultrasonography was a fundamental tool for prop-
erly classify and then apply a targeted approach to chronic pleu-
ral empyema, but other studies are necessary to standardize its
application and identify its predictive value.
CONCLUSIONS
Uniportal thoracoscopic decortication for pleural empyema,
even in stage III, is a safe and effective approach for well-selected
patients based on a combination of clinical and imaging staging.
Ultrasonography is a useful and non-invasive tool for identifying
empyema stages, for planning the surgical approach and access,
and also ultrasonographic patterns well corresponded with
intraoperative pleural findings.
Conflict of interest: none declared.
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